[Cytostatic therapy of hemoblastosis].
D000293:Adolescent; D000477:Alkylating Agents / Q000627:therapeutic use*; D000963:Antimetabolites / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001772:Blood Cell Count; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D016403:Lymphoma, Large B-Cell, Diffuse; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D015122:Mercaptopurine / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000188:drug therapy*; D011087:Polycythemia Vera / Q000188:drug therapy
D000477:Alkylating Agents; D000963:Antimetabolites; D000970:Antineoplastic Agents; D005938:Glucocorticoids; D015122:Mercaptopurine
Zytostatische Therapie der Hämoblastosen.